SCHEMBL7752103

SCHEMBL7752103

CCN1CCCNCCNCCCNCC1

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 15/20 0.63
MEN1 O00255 1/20 0.55
CHRM2 P08172 1/20 0.55
CHRM1 P11229 1/20 0.55
ADRA2C P18825 1/20 0.55
CCR2 P41597 1/20 0.55
CXCL12 P48061 1/20 0.55
BLM P54132 1/20 0.55
KMT2A Q03164 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
HRH3 Q9Y5N1 1/20 0.55
SIGMAR1 Q99720 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHRM5 P08912 1/20 0.36
CHRM3 P20309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL772696 0.95
SCHEMBL3635506 0.95 CXCR4 (0.56) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL65385 0.95
Hydrochloric Acid SCHEMBL17164764 0.93 CXCR4 (0.54) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL3717269 0.93 CXCR4 (0.54) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL22871961 0.93 CXCR4 (0.52) CXCR4MEN1CHRM2CHRM1ADRA2C
Hydrochloric Acid SCHEMBL151951 0.91 CXCR4 (0.52) CXCR4MEN1CHRM2CHRM1ADRA2C
Hydrochloric Acid SCHEMBL15399694 0.91 CXCR4 (0.52) CXCR4MEN1CHRM2CHRM1ADRA2C
Hydrochloric Acid SCHEMBL155821 0.91 CXCR4 (0.52) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL6631857 0.91 CXCR4 (0.48) CXCR4MEN1CHRM2CHRM1ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117241781-A Loading of alginate microspheres 德克萨斯大学系统董事会 2023-12-15 CN disclosed
WO-2020065045-A1 LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PSMA-EXPRESSING CANCERS Universität Heidelberg (DE) 2020-04-02 WO disclosed
WO-2001046202-A1 POLYAZACYCLOALKANES, ORGANOMETALLIC COMPLEXES THAT INCORPORATE THEM AS LIGANDS AND THE USE OF SAID COMPOUNDS IN THE EXTRACTION OF HEAVY METALS L'AIR LIQUIDE SOCIETE ANONYME A DIRECTOIRE ET CONSEIL DE SURVEILLANCE POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2001-06-28 WO disclosed